RxDoctor Payments DataLook up a doctor →

Neil Caliman, MD

Anatomic Pathology & Clinical Pathology · Lansing, MINPI 1316041692

Payments from drug & device makers

$870,978in general payments, 2019–2025

Across 535 payments — averaging $1628.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$506K
  • CSL Plasma Inc.$365K
  • Tempus AI, Inc$46
  • Beckman Coulter, Inc.$17

What the payments were for

  • Consulting fees$870,915100%
  • Food & beverage$640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring301$506,224
CSL Plasma Inc.231$364,690
Tempus AI, Inc2$46
Beckman Coulter, Inc.1$17

How this compares

$870,978 in reported general payments places this provider in the 95th percentile of 201 anatomic pathology & clinical pathology providers in Michigan.

See all anatomic pathology & clinical pathology providers in Michigan

Medicare billing

Part B allowed, 2024
$113,883
Medicare patients
1,266
Services billed
3,405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →